17+? Distinguished speakers to share their insights

30+? Case studies from world-class top brands

200+? Marketing and communication professionals to network

?

Interweaving with big data, the Internet starts its time of digital marketing. It is researched that digitization has deeply penetrated daily behaviors of doctors and patients in China.

With the traditional marketing methods faced with its situation of depression, which is as cold as winter, there is still a little time difference between the rise of pharmaceutical industry′s online marketing and FMCG (fast-moving consumer goods) since the significant disparity with common fast-moving consumer goods on aspects of products, distribution channels, target groups. How will pharmaceutical industry embrace digital marketing in this round of wave represented by digital innovation? What is the current situation of pharmaceutical companies like? What problems and troubles did they meet in the process of development? Are there any successful implementation cases? What will the development trend be like in the future?

In this session, we will focus on

Pharmaceutical companies’ transformation, development trend and perspective about the prospect

How pharmaceutical companies can innovate digital communication tools and management platforms

Successful cases of digital marketing strategy concentrating on patients

Exploration of methods to digital marketing and the accurate marketing channel

Exploration of innovative business model and the best solution

Based on the advanced information technology and big data, how pharmaceutical companies can achieve its expected effects and the maximum ROI of pharma′s transformation to digitalization by combining the company′s features and product attributes with it

?

Why Should Attend?

Optimizing your organization’s digital footprint

Utilizing the right digital outlets to communicate with your audience

Understanding emerging new media trends such as WeChat, on/offline integration, Omni-channel, co-marketing etc.

Using social media, public relations, and advertising to create the “right” approach

Leveraging your audience to build brand advocates and fuel word of mouth campaigns

Better understanding of big data and how to analyze and put the results into action

Crafting new strategies to bring your strategy and campaigns to the next level

Who Should Attend?

GM, VP, Directors and managers with responsibilities in :

Digital Marketing

Interactive Marketing

Mobile Marketing

Online Marketing

Sales

Marketing

Public Relations

Customer Relations

Social CRM

Social Business

Social Community

Crisis Management

Commercial

Training

Education

Medical

Day-1 (Thursday, March 21)

Opportunity & Challenge (external Environment & Policy)

9:00-9:05 Opening of the Moderator

9:05-9:30

Empowering China Pharma Business Growth through Digital Sales 2.0

China faces a unique combination of challenges including healthcare budget constraints, long distances, compliance, remote access & infrastructure, making cost-effective accessibility a concern. However, the recent AIML technology and healthcare big data boom in China have shed lights on these barriers and ensured that innovative tech solutions are coming along. We unveil the latest in ‘virtual reps’ technology to ensure effective and efficient HCP engagements enabled by customer 360 profiles and precision targeting engine.

Kings Wang，Senior Director, Strategic Planning & Business Development, Head of Contract Sales & Medical Services, IQVIA Greater China

9:30-10:15

In the era of compliance, how to do better government affairs communication under the strategy of big health

Qing XI, Sr. Director, Government Affairs, Market Access & Communications, Pfizer China

10:15-10:45 ?Coffee Break

10:45-11:30

How technology innovation will improve outcomes for patients living with neurological conditions

?Aaron Tian, Head? of Neuroscience Patient Innovation China,UCB

11:30-12:15

Digital Health Solutions

Chinese consumers are highly receptive of digital commerce and the latest innovations. However, digital technologies haven't significantly transformed or disrupted the healthcare industry thus far. This presentation will look at the current pain points in chronic disease management and technology readiness, and talk about how to create better offerings, gather insights and improve patient outcomes.

John Ma, Senior Marketing Director, Strategic Planning and Commercial Innovation,Novo Nordisk

12:15-13:15 Lunch Break

13:15-14:15

Compliance following and digitalization ahead, changes and the unchanged in the marketing innovation of pharmaceutical equipment enterprises

Moderator :Roger Liu, Commercial Strategy & Excellence Vice President，AstraZeneca China
Marie CHAVANON, Head of Customer Innovation，Sanofi
Eva Liu，Marketing Director-Public Segment，GE Healthcare
Tianhong Tan，General Retail Manage，JD Pharma

Declan Rooney, Senior Director, Self Care Franchise Asia Pacific, Johnson & Johnson

Lu Yabin ，IT Functional Leadership, BCL-BS-IT-ITFL，Bayer (China) Ltd

Angela Xu，Chief Marketing Officer，Eli Lilly and Company

14:15-15:00

Open Innovation – challenges and opportunities to adapt to the digital landscape

While historically corporate innovation efforts have been siloed within research labs and boardrooms, in today’s rapidly moving environment, companies cannot afford to keep their closed models and have to reach beyond traditional borders to improve the speed, quality and cost of innovation. This presentation will look at the challenges and opportunities of Open Innovation in MNCs and how to drive it

Marie CHAVANON, Head of CustomerInnovation,Sanofi

15:00-15:30 Coffee Break

15:30-16:15

How digital marketing enable medical device business and precision health?

Nowadays in the digital era, when we talk about digitalmarketing, we are talking about not only cost control, more coverage or better ROI, but also the commitment of making a difference to customers’ outcome.. This speech is sharing some digital marketing practice and digital tools, focusing on customers’ challenge in the journey of precision health, which leads to win-win outcomes for medical device business.

Eva Liu，Marketing Director-Public Segment，GE Healthcare

16:15-17:00

Explore a new patient-centered business model

Kevin Li，VP, Emerging Market CIO at GSK

17:00-17:45

Digital Innovations in Pharmaceutical Sales & Marketing: how to create 360 degree view and combine with classical non-digital innovations

?In this talk we discuss Digital Innovations in Pharmaceutical Sales & Marketing and how to create 360 degree view and combine with classical non-digital innovations. It is very important to coordinate digital innovations with non-digital activities, field force, sampling, and other programs. We also discuss challenges of this integration and how to create a perfect coordination to achieve results.”

Igor Rudychev, PhD, MBA (Booth)，Sr. Director, Insights and Analytics–Hematology & Faslodex，AstraZeneca Pharmaceuticals

標(biāo)準(zhǔn)價(jià)12800（費(fèi)用包含：場(chǎng)地費(fèi)，4場(chǎng)茶歇，五星級(jí)自助午餐，￥3500會(huì)務(wù)資料）